Palprostes (Capsules) Instructions for Use
Marketing Authorization Holder
TAD PHARMA GmbH (Germany)
Manufactured By
Swiss Caps AG (Switzerland)
Labeled By
SWISS CAPS, AG (Germany)
ATC Code
G04CX02 (Serenoa repens fruits)
Active Substance
Serenoa repens (BP British Pharmacopoeia)
Dosage Form
| Palprostes | Capsules 320 mg: 30 or 60 pcs. |
Dosage Form, Packaging, and Composition
| Capsules | 1 caps. |
| Saw palmetto fruit extract | 320 mg |
15 pcs. – blisters (2) – carton packs.
15 pcs. – blisters (4) – carton packs.
Clinical-Pharmacological Group
Herbal preparation used for functional urinary disorders associated with benign prostatic hyperplasia
Pharmacotherapeutic Group
Herbal remedy for the treatment of prostate adenoma
Pharmacological Action
Saw palmetto fruit extract reduces edema and obstruction in the periglandular, proper stromal, and glandular tissues of the prostate gland.
It increases the activity of the enzyme 3α-hydroxysteroid oxidoreductase (3α-HSOR), involved in the metabolism of dihydrotestosterone (DHT), and the enzyme creatine kinase in the prostate tissue.
An increase in the content of myristic and lauric acids, contained in the Palprostes preparation, can be observed in the prostate tissue.
In vitro experiments have demonstrated suppression of 5α-reductase activity under the influence of these acids.
Pharmacokinetics
Studies of pharmacokinetic properties have not been conducted because saw palmetto fruit extract is a multicomponent mixture, and studying its pharmacokinetics is not feasible.
Indications
- benign prostatic hyperplasia (stage I and II);
- As part of complex therapy for chronic prostatitis to eliminate dysuric symptoms (urination disorder, nocturnal pollakiuria, pain syndrome, etc.).
ICD codes
| ICD-10 code | Indication |
| N40 | Hyperplasia of prostate |
| N41 | Inflammatory diseases of prostate |
| ICD-11 code | Indication |
| GA90 | Hyperplasia of prostate |
| GA91.Z | Inflammatory and other diseases of prostate, unspecified |
Dosage Regimen
| The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen. |
Orally, daily, preferably at the same time, after meals, 1 capsule once a day. The capsules should be swallowed whole, without chewing, with a small amount of liquid.
The drug Palprostes is recommended to be taken long-term. The duration of the treatment course is at least 3 months. The optimal regimen and repeated courses of treatment are determined and prescribed by the doctor individually in each case based on the patient’s diagnostic examination.
Adverse Reactions
From the digestive system gastrointestinal disorders (nausea, vomiting, abdominal pain, diarrhea).
From the cardiovascular system arterial hypotension, fainting.
From the nervous system impaired coordination of movements.
Other allergic reactions.
Contraindications
- Children under 18 years of age (lack of clinical studies on the use of the drug in children);
- Hereditary fructose intolerance;
- Hypersensitivity to any of the components of the drug.
Pediatric Use
Contraindicated in children under 18 years of age.
Special Precautions
Before prescribing the saw palmetto fruit preparation, it is necessary to ensure that the disease is benign.
Patients taking the drug Palprostes for a long time should undergo regular medical check-ups. If the patient’s condition worsens while taking the drug, and symptoms such as arterial hypotension, impaired coordination of movements, fainting, traces of blood in the urine, or acute urinary retention appear, it is necessary to discontinue the drug and consult a doctor.
Effect on the ability to drive vehicles and mechanisms
When using the drug Palprostes, one should exercise particular caution when driving vehicles and engaging in other potentially hazardous activities that require increased concentration and speed of psychomotor reactions.
Overdose
An increase in the severity of side effects from the gastrointestinal tract organs is possible.
Treatment symptomatic.
Drug Interactions
No data on interaction with other medicinal products.
Storage Conditions
At a temperature not exceeding 30°C (86°F). Keep out of reach of children.
Shelf Life
The shelf life is 3 years.
Dispensing Status
Without a prescription.
Important Safety Information
This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.
Medical Disclaimer
Mildronate capsules 500mg, 90pcs
Belosalic, ointment, 30g
No-spa pills 40mg, 64pcs
Actovegin pills 200mg, 50pcs
Cortexin, 10mg, 5ml, 10pcs
Belosalic, lotion solution for external use spray 100ml
Daivobet, ointment, 30g
Kagocel pills 12mg, 30pcs
Picamilon pills 50mg, 60pcs
Cavinton Comfort, dispersible pills 10mg 90pcs
Ingavirin capsules 90mg, 10pcs
Fenotropil pills 100mg, 60pcs
Cerebrolysin, solution for injection 2ml ampoules 10pcs
Nootropil pills 800mg, 30pcs
OKI, sachets 80mg 2g, 12pcs
Noopept, pills 10mg, 50pcs
Arbidol, capsules 100mg, 40pcs
Phenibut-Vertex pills 250mg, 20pcs 